1269753

Apotex Inc. — FEI 3002906944

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 31, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
North York (Canada)

Additional Details

Postmarket Adverse Drug Experience (PADE)